Year: 2025
Type: article
Study design: Observational Study
Abstract: Adverse events (AEs) following immunization can include autoimmune AEs for some vaccines and combinations. This study retrospectively examines autoimmune AEs to detect safety signals for vaccines and concomitantly administered vaccines in the Vaccine Adverse Event Reporting System (VAERS) database. This study focuses on which vaccines were administered or coadministered for retrospective analysis of analyzed autoimmune AEs. Observed results include multiple autoimmune AE safety signals: human papillomavirus (HPV) Cervarix, HPV Gardasil, hepatitis (Hep) A + Hep B (Twinrix), Lyme disease (LYMErix), coadministered COVID-19 Moderna + Pfizer-BioNTech, Hep B (Engerix-B), and others. Identified arthritis AE safety signals include Lyme disease (LYMErix), rubella (Meruvax II), HPV (Cervarix), Anthrax (Biothrax) + Smallpox (Dryvax), and more. Coadministered DTaP + HepB + IPV (Pediarix) + Hib (Pedvaxhib) + Pneumococcal (Prevnar13) + Rotavirus (Rotarix) may be exhibiting synergy AE rate for eczema AEs. Thirty five influenza vaccines were observed with Guillain–Barré syndrome (GBS) AE safety signals, plus additional safety signals for multiple other vaccines. influenza (H1N1 monovalent) (GSK) exhibits a very high rate for narcolepsy AEs.
Source: Immune discovery.
Author: Darrell O. Ricke
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4413119199